Key facts
- This page summarizes DANAHER CORP /DE/'s Form 4 filing for Codex DNA, Inc. (TBIO).
- 3 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 24 Jun 2021, 16:51.
DANAHER CORP /DE/ - 22 Jun 2021 Form 4 Insider Report for Codex DNA, Inc. (TBIO)
- Reporting relationship
- 10%+ Owner
- Issuer ticker
- TBIO
- Reported as of
- 22 Jun 2021
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 24 Jun 2021, 16:51:32 UTC
- Prior SEC filing
- 24 Jun 2021
- Next SEC filing
- 11 Sep 2023
- Source filing
- View source filing
- Reporting owner signature
- Danaher Corporation /s/ James F. O'Reilly, Vice President, Deputy General Counsel and Secretary
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
DANAHER CORP /DE/ filed Form 4 for Codex DNA, Inc. (TBIO) on 24 Jun 2021.
Change
- Previous filing in this sequence was filed on 24 Jun 2021.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
TBIO
transaction
Common Stock
Conversion of derivative security
- Transaction value
- $0
- Shares
- +2,294,157
- Change %
- Price
- $0.000000
- Shares after
- 2,294,157
- Date
- 22 Jun 2021
- Ownership
- By Danaher Innovation Center LLC
- Footnotes
- F1, F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
TBIO
transaction
Derivative
Series A Preferred Stock
Conversion of derivative security
- Transaction value
- $0
- Shares
- -1,751,999
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 22 Jun 2021
- Ownership
- By Danaher Innovation Center LLC
- Underlying class
- Common Stock
- Underlying amount
- 1,751,999
- Exercise price
- Footnotes
- F1, F2
TBIO
transaction
Derivative
Series A-1 Preferred Stock
Conversion of derivative security
- Transaction value
- $0
- Shares
- -542,158
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 22 Jun 2021
- Ownership
- By Danaher Innovation Center LLC
- Underlying class
- Common Stock
- Underlying amount
- 542,158
- Exercise price
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Section 16 status
DANAHER CORP /DE/ is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.
Explanation of responses 2 footnotes
Footnote F1
Each share of Series A Preferred Stock and Series A-1 Preferred Stock (collectively, the "Preferred Stock"), par value $0.0001 per share, of the Issuer automatically converted on a one-for-one basis to shares of the Issuer's common stock, par value $0.0001 per share ("Common Stock"), immediately prior to the closing of the Issuer's initial public offering of its Common Stock. The right to convert the Preferred Stock into Common Stock had no expiration date.
Footnote F2
Held by Danaher Innovation Center LLC. Danaher Innovation Center LLC is an indirect, wholly owned subsidiary of Danaher Corporation. The address of Danaher Innovation Center LLC is 2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC 20037.